LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-13 Cr | ₹39 Cr | ₹-12 Cr | ₹-61 Cr | ₹-5.55 Cr |
What is the latest Consolidated Net Profit of LYKA LABS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-13 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹-12 Cr |
Mar2021 | ₹-61 Cr |
Mar2020 | ₹-5.55 Cr |
How is Consolidated Net Profit of LYKA LABS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-13 Cr | Negative | |
Mar2023 | ₹39 Cr | Positive | |
Mar2022 | ₹-12 Cr | Negative | |
Mar2021 | ₹-61 Cr | Negative | |
Mar2020 | ₹-5.55 Cr | - |
Compare Consolidated Net Profit of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹382.3 Cr | 6.7% | 6.1% | -6.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,988.0 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 6.7% |
6.1% |
-6.1% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses